In-vitro release and in-vivo performance of tolmetin from different topical gel formulations
Tóm tắt
This study was designed to evaluate the suitability of Pluronic F-127, different grades of Carbopol and cellulosic polymers as gel bases containing tolmetin, a non-steroidal anti-inflammatory drug. In vitro release characteristics, effect of enhancers, viscosity and the mechanism of drug release for different gel bases was studied as well as the anti-inflammatory activity were evaluated. The results showed that the HPMC gel has the superior percent of drug release than the others. The percent released of drug from Carbopol and the Pluronic F-127 gels is concentration defendants. It was found that the drug release from the tested gel bases obeyed the diffusion mechanism. The use of propylene glycol and urea in different concentrations (3.0, 5.0 and 10 % w/v) had enhanced the percent of drug release significantly (p < 0.05). The anti-inflammatory activity of the drug in Carbopol gel formulation showed excellent anti-inflammatory activity. These finding highlight the potential local application of tolmetin gel as topical anti-inflammatory medication.
Tài liệu tham khảo
Arellano SS, Martin C, Ygartua P (1996) Enhancing effect of terpenes on the in vitro percutaneous absorption of diclofenac sodium. Int J Pharm 130:141–145
Babar A, Solanki UD, Cutie AJ (1990) Piroxicam release from dermatological bases: in vitro studies using cellulose membrane and hairless mouse skin. Drug Dev Ind Pharm 16:523–540
Cooper ER (1990) Practical consideration for topical drug, formulations with and without enhancers. In: David AW, Anton HA (eds) Topical delivery formulations. Marcel Dekker Inc, New York, p 10
EL Maghraby GM (2008) Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: effect of cosurfactant. Int J Pharm 355:285–292
El-Badry M (2009) Preparation, in-vitro release and anti-inflammatory activity of meloxicam in different gel formulations. Bull Pharm Sci Assiut Univ 32:213–224
El-Badry M, Fetih G (2011) Preparation, characterization and anti-inflammatory activity of celecoxib chitosan gel formulations. J Drug Deliv Sci Technol 21(2):201–206
Escribano E, Calpena AC, Queralt J, Obach R, Domenench J (2003) Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula. Eur J Pharm Sci 19:203–210
Goffin V, Henry F, Piérard-Franchimont C, Piérard GE (2000) Penetration enhancers assessed by corneoxenometry. Skin Pharmacol Appl Skin Physiol 13:280–284
Gupta SK, Bansal P, Bhardwaj RK, Jaiswal J, Velpandian T (2001) Comparison of analgesic and anti-inflammatory activity of meloxicam gel with diclofenac and piroxicam gels in animal models: pharmacokinetic parameters after topical application. Skin Pharmacol 15(2):105–111
Gupta M, Marwaha RK, Verma PRP, Singh G, Faruk A (2008) Formulation and evaluation of meloxicam gels. J Pharm Res 7:27–31
Guzman M, Aberturas MR, Garcia F et al (1994) Gelatine gels and polyoxyethylene-polyoxypropylene gels: comparative study of their properties. Drug Dev Ind Pharm 20:2041–2048
Habib FS, El-Shanawany SM (1989) Release study of dexamethasone from different ointment bases. Bull Pharm Sci Assiut Univ 12(1):90–102
Hiramatsu Y, Akita S, Salamin PA, Maier R (1990) Assessment of topical non-steroidal anti-inflammatory drugs in animal models. Arzneim Forsch 40:1117–1124
Huang YB, Wang RJ, Chang JS, Tsai YH, Wu PC (2007) Evaluation of ketoprofen formulations via penetration rate and irritation in vivo study. Int J Pharm 339(1):47–51
Katzung BG (2004) Basic and clinical pharmacology, 9th edn. McGraw Hill, New York
Lauffer MA (1961) Theory of diffusion in gels. Biophys J 1:205–213
Lindsley CB (1999) Non-steroidal anti-inflammatory drugs: renal toxicity. Clin Pediatr 29(1):10–12
Macedo T, Lawrence HB, Shukla AJ (1993) Release of tolmetin from carbomw gel systems. Drug Dev Ind Pharm 19:887–902
Miyazaki S, Yokouchi C, Nakamura T et al (1986) Pluronic F-127 gels as a novel vehicle for rectal administration of indomethacin. Chem Pharm Bull 34:1801–1808
Padi SS, Jain NK, Singh S et al (2004) Pharmacological profile of parecoxib: a novel, potent injectable selective cyclooxygenase-2 inhibitor. Eur J Pharmacol 491(1):69–76
Pinto L, Borrelli F, Bombardelli E et al (1998) Anti-inflammatory, analgesic and antipyretic effects of glaucine in rats and mice. Pharm Pharmacol Commun 4:502–505
Prakash PR, Rao NR, Chowdary S (2010) Formulation, evaluation and anti-inflammatory activity of topical etoricoxib gel. Asian J Pharm Clin Res 3:126–129
Rafiee TM, Mehramizi A (2000) In vitro release studies of piroxicam from oil-in-water creams and hydroalcoholic gel topical formulations. Drug Dev Ind Pharm 26:409–414
Shin SC, Cho CW, Oh IJ (2000) Enhanced efficacy by percutaneous absorption of piroxicam from the poloxamer gel in rats. Int J Pharm 193(2):213–218
Singh UV, Pandey S, Udupa N (1994) Communications drug carriers for transdermal preparations of flurbiprofen. Drug Dev Ind Pharm 20:1811–1820
Suh H, Jun HW (1995) Physicochemical and release studies of naproxen in poloxamer gels. Int J Pharm 129:13–20
Varshosaz J, Tabbakhian M, Salmani Z (2008) Design of a thermosensitive chitosan/poloxamer in situ gel for ocular delivery of ciprofloxacin. Open Drug Deliv J 2:61–70
Winter CA, Edwin AR, George WN (1962) Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Exp Biol Med 111(3):544–547